29 results on '"Novella-Navarro M"'
Search Results
2. AB0897 PREDICTIVE MODELS TO FORECAST DIFFICULT-TO-MANAGE AXIAL SPONDYLOARTHRITIS
3. POS0941 INTENSIVE REDUCTION OF SERUM URIC ACID WITH URICASE EFFECT THROUGH THE COMBINATION OF BENZBROMARONE AND FEBUXOSTAT IN PATIENTS WITH DIFFICULT-TO-TREAT TOPHACEOUS GOUT
4. POS0681 ARE JAKi PLASMA LEVELS RELATED TO CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS?: THE MEASURE STUDY, A MULTICENTRE PROSPECTIVE COHORT STUDY
5. Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study
6. AB0375 DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS (D2T-RA): CLINICAL ISSUES AT EARLY STAGES OF DISEASE
7. POS0587-HPR IMPACT OF COMBINED INTERVENTION WITH CLINICAL NURSE SPECIALIST IN THE MANAGEMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH GOUT
8. AB0410 OBESITY AND ADIPOSE TISSUE CYTOKINES IN RHEUMATOID ARTRHITIS: DOES THE ROUTE OF ADMINISTRATION OF THE IL6 INHIBITORS MATTER?
9. POS0676 THE CHALLENGE OF IDENTIFYING DIFFICULT-TO-TREAT AXIAL SPONDYLOARTHRITIS IN CLINICAL PRACTICE: RESULTS FROM LA PAZ-SPA COHORT
10. POS0563 USE OF A DIGITAL SOLUTION TO MONITOR CHRONIC INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: FINAL RESULTS OF THE DIGIREUMA STUDY
11. POS0783 ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND SALIVARY GLAND ULTRASOUND FINDINGS IN PATIENTS WITH SUSPECTED PRIMARY SJÖGREN SYNDROME
12. POS0647 DOES TNF INHIBITOR MOLECULAR STRUCTURE MATTER? ANALYSIS OF IMPACT OF BASELINE RHEUMATOID FACTOR TITERS ON DRUG LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
13. POS0264 CHARACTERIZATION OF THE IMMUNE RESPONSE IN PATIENTS WITH INFLAMMATORY IMMUNE-MEDIATED DISEASES ON IMMUNOSUPPRESSIVE TREATMENT AFTER ONE MONTH OF SARS-CoV-2 VACCINATION
14. POS1170 ASYMPTOMATIC URATE-CRYSTALS DEPOSITS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE DETECTED BY ULTRASOUND
15. AB0367 THE PARADIGM OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: SUBTYPES AND EARLY IDENTIFICATION.
16. AB0149 CHARACTERISATION OF RHEUMATOID ARTHRITIS PROGRESSION IN AN EARLY UNDIFFERENTIATED ARTHRITIS COHORT
17. AB0027 INCREASED CIRCULATING CD39+FOXP3+CD4+ TREG CELLS IN EARLY RHEUMATOID ARTHRITIS FACILITATE THE ANTIINFLAMMATORY ACTION OF METHOTREXATE
18. POS0617 ANTI INFLIXIMAB ANTIBODIES DETECTED BY A DRUG TOLERANT ASSAY ARE FREQUENT BUT, IN MANY CASES, WITHOUT RELEVANT CLINICAL SIGNIFICANCE
19. 4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study
20. AB0221 ULTRASOUND ASSESSMENT OF INFLAMMATORY ARTHRALGIA: PREDICTORS FOR CHRONIC ARTHRITIS DEVELOPMENT
21. AB0313 CLINICAL PREDICTORS OF MULTIPLE FAILURES TO BIOLOGICAL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS.
22. AB0646 IS IT FEASIBLE TO ACHIEVE RECOMMENDED THERAPEUTICAL TARGET IN PATIENTS WITH AXIAL SPONDYLARTHRITIS IN CLINICAL PRACTICE? DATA FROM THE SpA-Paz COHORT
23. FRI0086 DISEASE ACTIVITY MEASURES AND OTHER POTENTIAL PREDICTORS OF SUCCESSFUL TNF INHIBITORS TAPERING IN RA PATIENTS
24. AB0214 4-YEAR EXPERIENCE OF AN OUTPATIENT CLINIC OF PATIENTS WITH CLINICALLY SUSPECTED ARTHRALGIAS OF EVOLVING TO ARTHRITIS
25. THU0170 BAFF CONTRIBUTES TO THE DEVELOPMENT OF IMMUNOGENICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS
26. AB0437 RISK FACTORS ASESSMENT FOR SUBCLINICAL ARTHEROSCLEROSIS IN PRIMARY SJÖGREN´S SYNDROME.
27. SAT0084 SERUM ADIPOKINES PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF-INHIBITORS
28. AB0741 IS THE THERAPEUTIC TARGET ACHIEVEMENT INCREASING OVER TIME IN PATIENTS WITH PSORIATIC ARTHRITIS STARTING BIOLOGICAL THERAPY? DATA FROM 15 YEARS.
29. SAT0368 Role of joint ultrasonography in patients with gout starting treatment with febuxostat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.